About Nanosonics Limited (NNCSF) — Dividend Analysis 2026
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Is NNCSF a good dividend investment in 2026?
NNCSF offers a 91.32% forward yield with a 50% payout ratio. Strand Safety Score: 45/100 (Moderate Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
NNCSF DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your NNCSF portfolio grows to $21.14M vs $9.45M without reinvestment. This is the compound interest effect in action.
NNCSF dividend growth history & forecast
NNCSF has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 91.32%.
FCF ($35M) is below dividends paid ($607M) — risk of cut (FCF: $35M · Dividends est.: $607M)
Debt Leverage0.0× Debt/EBITDA
30 / 30 pts
30/30
Debt/EBITDA 0.0× — low leverage, balance sheet is strong
Earnings Momentum+0.0B → +0.0B → +0.0B
15 / 30 pts
15/30
Net income grew in the latest year — positive but trend is unconfirmed
OVERALL ASSESSMENT
Dividend at moderate risk — monitor coverage and debt closely.
STRAND SCORE
45
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 NNCSF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NNCSF.
Gross yield
91.32%
Tax rate
15.00%
After-tax yield
77.62%
Real yield (−CPI)
74.82%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
91.32%
88.52%
$9,132 / yr
🇺🇸 US Taxable (15%) ✓
15%
77.62%
74.82%
$7,762 / yr
🇺🇸 US Taxable (20%)
20%
73.06%
70.26%
$7,306 / yr
🇬🇧 UK ISA
0%
91.32%
88.52%
$9,132 / yr
🇬🇧 UK Taxable
8.75%
83.33%
80.53%
$8,333 / yr
🇨🇦 TFSA
0%
91.32%
88.52%
$9,132 / yr
🇨🇦 CA Taxable
25%
68.49%
65.69%
$6,849 / yr
🇦🇺 Super (pension)
15%
77.62%
74.82%
$7,762 / yr
🇦🇺 AU Taxable
30%
63.92%
61.12%
$6,392 / yr
🇩🇪 DE Taxable
26.375%
67.23%
64.43%
$6,723 / yr
🇫🇷 FR Taxable
30%
63.92%
61.12%
$6,392 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NNCSF Income Goal & Break-Even
Dividend Break-Even
2yr
Years for dividends to fully repay your NNCSF investment of $2.19/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$138.5K
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$136.0K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in NNCSF for:
Shares needed
14,118
Capital required
$30,918
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NNCSF Dividend Payment Schedule
NNCSF pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 NNCSF vs Healthcare Benchmarks
How NNCSF compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+88.52% vs sectorBetter
NNCSF
91.32%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
NNCSF
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
NNCSF
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NNCSF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NNCSF Insider Activity
No recent SEC filings reported in the last 90 days.
🔬
Financial Health Scores
Altman Z-Score
12.76
✅ Safe Zone — low bankruptcy risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
5/9
⚠️ Moderate fundamentals
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NNCSF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →